Post-line Treatment With Teniposide for c-Myc-driven Extensive-stage Small Cell Lung Cancer

计划入组 15 人 · 首次发布于 2025 年 1 月 6 日

Testing the Safety of Anti-Cancer Drug, CX-5461 (Pidnarulex), in Treating Lymphoma With Specific Changes in the MYC Gene

计划入组 50 人 · 首次发布于 2025 年 7 月 17 日

A Feasibility Study of Gallium-68 Citrate PET to Detect Aberrant MYC Proto-Oncogene, BHLH Transcription Factor (MYC) Protein Expression in Diffuse Large B-Cell Lymphoma

首次发布于 2016 年 5 月 18 日

MYC-053

Myc-102

DCR-M1711

AUSTRALASIAN LEUKAEMIA & LYMPHOMA GROUP

Australia

ASSOCIATION INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP (IELSG)

Switzerland

Viridian Metals Inc

United States

CRISPR Screen Identifies GATOR1 Complex as Key Suppressor of MYC-Driven Lymphomas with Therapeutic Implications

FDA-Approved Heart Drug Dronedarone Shows Promise as Novel Lymphoma Treatment Through USP11 Enzyme Targeting

NCI Initiates $4.8 Million Clinical Trial of Senhwa's First-in-Class Cancer Drug CX-5461